Shares of Sage Therapeutics were climbing fast on Thursday after the company announced positive mid-stage trial results on one of its depression drugs. The company saw its market cap soar over $2.5 billion as traders gobbled up shares. Shares closed up over 70%. It was the biggest one day ever price percentage gain for the … Continue reading “Sage Therapeutics Shares Skyrocket on Positive Depression Drug Trial Results”
